LEADER 02146oam  2200577   450 
001 9910708163603321
005 20151103151138.0
035   $a(CKB)3460000000114669
035   $a(OCoLC)654487597$z(OCoLC)654654379$z(OCoLC)761170162$z(OCoLC)806783697
035   $a(EXLCZ)993460000000114669
100   $a20100810d1998      ua             0
101 0 $aeng
135   $aurbn||||a||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aPatient access to alternative treatments $ebeyond the FDA : hearings before the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, February 4 and 12, 1998
210  1$aWashington :$cU.S. Government Printing Office,$d1998.
215   $a1 online resource (iv, 337 pages) $cillustrations
300   $aTitle from title screen (viewed on Nov. 3, 2015).
300   $a"Serial no. 105-103."
320   $aIncludes bibliographical references.
517   $aPatient access to alternative treatments 
606   $aAlternative medicine$xGovernment policy$zUnited States
606   $aHealth services accessibility$xGovernment policy$zUnited States
606   $aMedical policy$zUnited States
606   $aAlternative medicine$xGovernment policy$2fast
606   $aHealth services accessibility$xGovernment policy$2fast
606   $aMedical policy$2fast
607   $aUnited States$2fast
608   $aLegislative hearings.$2lcgft
615  0$aAlternative medicine$xGovernment policy
615  0$aHealth services accessibility$xGovernment policy
615  0$aMedical policy
615  7$aAlternative medicine$xGovernment policy.
615  7$aHealth services accessibility$xGovernment policy.
615  7$aMedical policy.
801  0$bOCLCE
801  1$bOCLCE
801  2$bOCLCO
801  2$bOCLCQ
801  2$bOCLCA
801  2$bOCLCF
801  2$bOCLCQ
801  2$bOCLCO
801  2$bOCLCA
801  2$bGPO
906   $aBOOK
912   $a9910708163603321
996   $aPatient access to alternative treatments$93503526
997   $aUNINA